Home BioDelivery Sciences

BioDelivery Sciences

In operation
Post-IPO Round
Pharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

BioDelivery Sciences (“BDSI”®) is a specialty pharmaceutical company focused on pain management and addiction medicine. They are leveraging their novel and proprietary BioErodible MucoAdhesive (BEMA®) drug delivery technology to independently or collaboratively develop and commercialize new applications of proven therapies with third parties, addressing significant unmet medical needs.
BioDelivery Sciences International, Inc.
Raleigh,NorthCarolina,United States of America
101~500 people
January 01, 1997
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Therapeutic Products # Pain
Application Scenarios
Innovative Drugs